powered by Sexual Health.com
Order | My Account | Questions? Call (000) 000-0000


STD News Topics

All Stories STD News Archive

STD Articles

10 Myths About STDs STDs Are Common Am I At Risk?

Resources

Editorial Staff STD Fast Facts STD Testing Glossary

Have Questions?

Call and speak to a counselor.

Hours: Mon - Sun 7am - 10pm CT

STD News >

Prevalence of hepatitis C increasing in Massachusetts due to intravenous drug use

Lisa Oldson, MD May. 09, 2011

Although blood screening technology has helped reduce the number of new hepatitis C infections over the past several decades, health officials in Massachusetts say that the prevalence of the disease is now back on the rise due to a surge in the number of adolescent intravenous drug users in the state, according to a recent article published by Reuters Health.

"Of cases with available risk data, injection drug use was the most common risk factor for HCV transmission," said members of the Massachusetts Department of Health, quoted by the news provider.

The experts noted that data indicated an increasing trend of heroin use among adolescent Caucasians between the ages of 15 and 24.

The news source reports that out of nearly 1,200 hepatitis C cases in the state, 72 percent of these individuals indicated that they used drugs presently or in the past.

More than 3 million Americans are chronically infected with hepatitis C, according to the Centers for Disease Control and Prevention. Nationwide, intravenous drug use is the cause of about one-third of these cases, the organization notes.

Related Articles

Survey finds baby boomers are in the dark about hepatitis C
Get ready for National Hepatitis Testing Day
Health officials concerned over hepatitis C rates in New York
Researchers find a high number of hepatitis C cases in Philadelphia
Conference to discuss new treatments for hepatitis C